Harry Samaroo
Pfizer (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Alzheimer's disease research and treatments, Cellular transport and secretion, Dementia and Cognitive Impairment Research, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression(2015)245 cited
- → Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis(2011)177 cited
- → Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1(2013)66 cited
- → High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain(2011)22 cited
- Enhanced endothelial cell density on NiTi surfaces with sub-micron to nanometer roughness(2008)
- → Adhesion and rouleau formation of red cells in a shear flow(2007)
- → P2‐084: Application of object‐based image analysis and virtual microscopy to quantify Alzheimer's disease neuropathology(2008)
- → P1‐031: [3H]DAA1106 binding to hippocampal peripheral benzodiazepine receptors in kainic acid‐treated Tg2576 and C57BL6 mice(2009)